US20010010238A1 - Fillable cassette apparatus and method - Google Patents
Fillable cassette apparatus and method Download PDFInfo
- Publication number
- US20010010238A1 US20010010238A1 US09/809,479 US80947901A US2001010238A1 US 20010010238 A1 US20010010238 A1 US 20010010238A1 US 80947901 A US80947901 A US 80947901A US 2001010238 A1 US2001010238 A1 US 2001010238A1
- Authority
- US
- United States
- Prior art keywords
- cassette
- drug
- inner reservoir
- delivery conduit
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
- A61M5/14228—Pumping with an aspiration and an expulsion action with linear peristaltic action, i.e. comprising at least three pressurising members or a helical member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1407—Infusion of two or more substances
- A61M5/1409—Infusion of two or more substances in series, e.g. first substance passing through container holding second substance, e.g. reconstitution systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/04—Tools for specific apparatus
- A61M2209/045—Tools for specific apparatus for filling, e.g. for filling reservoirs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/12—Pressure infusion
Definitions
- the present invention is directed to a cassette for use with a drug pump for administering drugs and a method for administering drugs, and more particularly to a cassette and method that allows improved filling of a cassette with a drug.
- Various ambulatory medical devices are known for treating and/or monitoring patients at a remote site away from the caregiver's or clinician's office.
- a drug delivery device such as a drug pump
- Ambulatory drug pumps are shown for example in U.S. Pat. Nos. 4,559,038, 5,531,697 and 5,695,473, the disclosures of which are incorporated by reference.
- Ambulatory drug pumps typically provide the patient with a drug or agent in liquid form, administering the liquid to the patient through a flexible conduit.
- Some drugs are sold in a powdered form. Examples of drugs on the market today that are sold in powder form include ampicillin, vancomycin hydrochloride, penicillin, nafcillin, and DesferalTM deferoxamine mesylate. Before powdered drugs are administered, they must be mixed with a liquid agent. When powdered drugs are dispensed at pharmacies, the pharmacist typically adds a liquid agent, such as a diluent, to the powdered drug at the pharmacy and then gives the drug to the patient in a liquid form, for example, in a drug pump cassette.
- a liquid agent such as a diluent
- liquid agents that may be mixed with powdered drugs are sterile water, dextrose and saline. These mixing steps require significant pharmacist time and may cause a long wait for a patient who is filling the prescription.
- Current ambulatory drug pump cassettes do not conveniently allow the patient to perform the dilution or reconstitution of a powdered drug, so the patient must visit the pharmacist.
- Certain types of drugs such as ampicillin have limited stability in liquid form. These drugs must be mixed with a liquid agent only a short period of time before they are administered to the patient. The short-lived stability of these drugs necessitates frequent trips by the patient to pick up the diluted drug or frequent deliveries of the diluted drug to the patient's location. In the alternative, some patients are taught to mix drugs with a liquid agent at home. If known drug cassette configurations are used, this process may be awkward and cumbersome for the patient.
- cassettes are filled by injecting fluid through a delivery conduit that is connected to the cassette reservoir.
- the delivery conduit is a tube that connects the cassette to the patient for drug delivery.
- Pharmacists will typically use a syringe or a pump to move the drug to be administered into the cassette reservoir.
- trapped air may be present in the cassette reservoir.
- the pharmacist will manually remove the trapped air from the cassette reservoir.
- the present invention concerns a drug pump cassette, including a housing that defines a transfer opening and a delivery opening.
- the cassette also includes an inner reservoir located within the housing.
- An access device, or valve, is also provided on the cassette.
- the valve has a first portion coupled to the inner reservoir at a transfer port and has a second portion coupled to the housing at the transfer opening.
- the cassette also includes a delivery conduit coupled to the inner reservoir at a delivery port, and emerging from the delivery opening of the cassette.
- the housing further includes a pressure plate supporting a portion of the delivery conduit.
- the pressure plate may be mounted to a control module of a pump.
- the drug cassette may also include a dispensing apparatus.
- the dispensing apparatus defines a passage and has a first activating device and a second activating device.
- the first activating device of the dispensing apparatus opens the valve of the cassette.
- the second activating device establishes fluid communication with a medicant container.
- the second activating device may include a spike used to pierce a septum of the medicant container, and an air vent to the atmosphere.
- the air vent may be provided with a filter.
- a liquid from a cassette is mixed with a powdered drug in a medicant container and the mixture is transferred back to the cassette.
- a liquid from a container is mixed with a powdered drug in a cassette reservoir.
- the inner reservoir of the cassette is evacuated through a second access port before filling the inner reservoir with the drug through the first access port, thereby providing a filled cassette with minimized trapped air.
- FIG. 1 is a perspective view of one embodiment of a cassette for use with a drug, a dispensing apparatus, and a medicant container.
- FIG. 2 is a side view of the cassette of FIG. 1 where the components are connected.
- FIG. 3 is a side view of the connected cassette of FIG. 2, positioned so that liquid within the cassette flows into the medicant container.
- FIG. 4 is a side view of the connected cassette of FIG. 2 positioned so that the drug in the medicant container flows back into the inner fluid reservoir of the cassette.
- FIG. 5A is a side view of a luer-activated valve that may be used with the cassette of FIG. 1.
- FIG. 5B is a cross-sectional side view of the luer-activated valve of FIG. 5A.
- FIG. 6A is a front view of a first embodiment of a dispensing apparatus for use with the present invention.
- FIG. 6B is a side view of the dispensing apparatus of FIG. 6A.
- FIG. 6C is a cross-sectional side view of the dispensing apparatus of FIG. 6A.
- FIG. 7 is a cross-sectional side view of a first portion of a second embodiment of a dispensing apparatus of the present invention.
- FIG. 8A is a front view of a second portion of the second embodiment of the dispensing apparatus of the present invention.
- FIG. 8B is a side view of the second portion of the dispensing apparatus of FIG. 8A.
- FIG. 8C is a cross-sectional side view of the second portion of the dispensing apparatus of FIG. 8A.
- FIG. 9 is a side view of an alternative embodiment of the cassette of the present invention where the components are connected in which an inner reservoir contains a powdered drug and a medicant container contains diluent liquid.
- FIG. 10 is a side view of an alternative embodiment of a cassette for use when mixing a drug or when using a method of the present invention to fill the cassette while minimizing trapped air.
- FIG. 11 is a perspective view of a drug pump control module.
- FIG. 12 is a side view of the cassette of the present invention during a mixing step.
- FIG. 13 is a plan view of a cassette filling system of the present invention for minimizing trapped air in the cassette.
- the present invention is applicable to a variety of systems and arrangements which are used to mix drugs before administration or to fill a cassette while minimizing trapped air before administration.
- the invention is advantageous in environments where a drug requires dilution or reconstitution immediately before administration.
- a cassette is described herein that allows a person, such as a patient, to easily mix a powdered drug with a liquid for administration with an ambulatory drug pump.
- the cassette of the present invention further enables the filling of the cassette so that trapped air is minimized.
- the cassette of the present invention includes an access mechanism that allows a user to empty at least a portion of liquid contents of the cassette into a medicant container to mix and/or dilute the drug in the container.
- the access mechanism then allows the user to transfer the mixed together contents of the container to the cassette for use with the drug pump.
- the access mechanism allows a user to add liquid to a powdered drug in the cassette.
- the access mechanism further permits evacuation of an inner reservoir of the cassette so that trapped air in the inner reservoir and a delivery conduit can be reduced before filling with a liquid drug.
- FIGS. 1 - 12 a system 20 including a cassette 100 , a dispensing apparatus 102 , and a medicant container 104 is shown according to one embodiment of the present invention.
- the cassette 100 is designed for use with a drug pump (or control module) 164 as shown in FIG. 11.
- a pressure plate 106 of the cassette 100 mounts to the control module 164 with two hooks 166 and an anchor 168 , illustrated in FIG. 1.
- the two hooks 166 engage two pins 188 .
- a latch 189 within the control module engages the anchor 168 .
- the cassette 100 further includes an inner reservoir 108 , such as a flexible polymeric bag. During administration of a liquid drug to a patient, the inner fluid reservoir 108 will contain the liquid drug.
- the inner fluid reservoir includes two openings: a delivery port 110 and a transfer port 112 , illustrated in FIG. 2.
- the two ports 110 , 112 of the inner reservoir 108 each communicate with openings in a housing 114 of the cassette 100 .
- the housing 114 defines a delivery opening 116 and a transfer opening 118 .
- the inner reservoir 108 is connected to a delivery conduit 120 , such as a compressible polymeric tube that emerges from the delivery opening 116 of the housing 114 .
- the delivery conduit 120 is supported by the pressure plate 106 of the cassette 100 .
- the portion of the delivery conduit that is supported on the pressure plate 106 is the pump portion 122 of the delivery conduit 120 .
- the pump portion 122 may be larger in size than the remainder of the delivery conduit 120 .
- a pumping mechanism 172 (FIG. 11) of the control module 164 will act on the pump portion 122 to draw the liquid drug out of the inner reservoir 108 and move it along the delivery conduit 120 .
- the delivery conduit 120 is connected to a patient for drug delivery.
- a luer fitting 109 or another type of connector and a cap 111 may be provided at the end of the delivery conduit 120 .
- the cassette 100 also includes an access mechanism for allowing selective access to the interior of the inner reservoir 108 .
- One preferred access mechanism includes a valve 124 capable of establishing fluid communication with the inner reservoir 108 in order to allow mixing with the contents of another container, such as the medicant container 104 .
- a dispensing apparatus 102 links the valve 124 of the cassette 100 with the medicant container 104 .
- the valve 124 of the illustrated preferred embodiment includes a first portion 126 that is operatively coupled to the inner fluid reservoir 108 at port 112 .
- the valve 124 further includes a second portion 128 that is attached to the housing 114 of the cassette 100 at transfer opening 118 .
- the valve 124 is capable of establishing fluid communication with the dispensing apparatus 102 when activated by the dispensing apparatus 102 .
- the valve 124 may be, for example, a luer-activated valve having a stopping member 152 that can be depressed by a luer fitting to open a passage 154 , as illustrated in FIGS. 5A and 5B.
- a biasing member 162 holds the stopping member 152 into engagement with the interior neck portion of the valve 124 .
- the first activating member 130 of the dispensing apparatus 102 may be a luer fitting that depresses the stopping member 152 .
- Many luer-activated valves are commercially available that may vary from the valve shown in FIGS. 5A and 5B, but could be used with the present invention.
- Dilution of a drug may easily be practiced using the present invention.
- the present invention is useful where two drug components must be mixed prior to administration to a patient using a cassette.
- Possible drug mixtures that could be carried out with the present invention include combining two liquids, or a solid and a liquid.
- the cassette 100 is attached to the dispensing member 102 , and fluid communication is established between the dispensing member 102 and the medicant container 104 .
- the cassette 100 will initially contain a liquid diluent 107 to be mixed with a powdered drug.
- diluents include sterile water, saline, and dextrose.
- the cassette 100 may also initially contain another type of liquid agent for mixing with a powdered drug.
- the medicant container 104 initially contains a powdered drug 105 to be administered to a patient.
- the dispensing apparatus 102 has a second activating member 132 for establishing fluid communication with the medicant container 104 .
- the medicant container 104 may be a vial with a sealed, pierceable septum 158 .
- the second activating member is a spike 134 that pierces the septum 158 and provides a passageway to the valve 124 .
- the dispensing apparatus also has a first activating member that is designed to open the valve 124 , such as a luer fitting if valve 124 is a luer-activated valve.
- the dispensing apparatus 102 includes two parts, a vented dispensing pin 138 and a male-to-male luer adapter 140 .
- a one piece dispersing apparatus 200 could be used in place of the two piece dispensing apparatus 102 .
- the one piece dispensing apparatus is illustrated in FIGS. 6 A- 6 C and is discussed further below.
- the two piece dispensing apparatus 102 is illustrated in FIG. 1.
- the venting dispensing pin 138 includes the second activating member, or spike, 134 , as shown in FIGS. 8 A- 8 C.
- the male-to-male luer adapter 140 includes the first activating member, a luer 136 for activating the valve 124 as shown in FIG. 7.
- the vented dispensing pin 138 includes a luer lock that attaches to the opposite end of the male-to-male luer adapter 140 , providing a passage for fluid communication.
- the dispensing apparatus 102 may be provided with an air vent 142 to more easily enable the flow of liquid between the cassette and the medicant container 104 by permitting displaced air or other gas to escape and allowing air to enter the connected cassette assembly, specifically the medicant container 104 .
- the air vent 142 is constructed according to known methods for permitting the flow of gas, but preventing the flow of liquid.
- the air vent 142 may include a hydrophobic membrane that is penetrable by gases but not by fluids.
- Vented dispensing pin 138 and male-to-male luer adapter 140 are commercially available as separate components.
- One example of a dispensing pin 138 that could be used as a portion of the dispensing apparatus 102 is the DP-1000 Mini-Spike® dispensing pin assembly, manufactured by Burron OEM, a division of B. Braun Medical, Inc.
- the preferred air vents 142 and 208 are similarly constructed.
- the liquid does not typically flow out of the air vent during filling or mixing, because the fluid tends to flow down the path of least resistance, therefore through the center passageway of dispensing pin.
- Another factor which prevents the air vent of the present invention from leaking fluid is the capillary action of the small tip of the spike tip. This spike tip and its small passage discourages flow toward the vent opening.
- a half-shield structure 149 or 209 at the vent 142 or 208 blocks some fluid flow out of the vent 142 or 208 .
- male-to-male luer adapter 140 that could be used as part of the dispensing apparatus 102 is the male/male luer lock connector, Model No. B1000200, manufactured by Burron OEM, a division of B. Braun Medical, Inc.
- the male-to-male luer adapter may be constructed of polycarbonate ABS, polypropylene or other similar material and is shown in FIG. 7 in detail.
- the adapter 140 defines a passage 190 .
- the luer fitting 136 of the adapter 140 depresses the stopping member 152 of the valve 124 when the adapter 140 is connected to the valve 124 .
- a second luer fitting 137 may also be included on the adapter 140 .
- a cap 144 may be used to protect the valve 124 before and after the mixing process and maintain aseptic conditions.
- a dispensing apparatus 200 could be made of only one piece as shown in FIG. 6A- 6 C, having both a first activating member 202 and a second activating member 204 on the same body connected in a permanent manner. In this embodiment there are fewer components for a user to connect.
- the one-piece dispensing apparatus 200 may include a luer fitting as the first activating member 202 .
- the first activating member 202 is designed to establish fluid communication with the valve 124 .
- the first activating member 202 , or luer may also include threads along the wall 205 , for receiving and securing the luer-activated valve or other type of valve. The threads would be similar to those illustrated in FIG. 7 near the activating members 136 and 137 .
- a second activating member 204 may be a spike to pierce the septum of the medicant vial.
- the one-piece dispensing apparatus 200 also defines a passage 206 through its length. An air vent 208 may also be provided on the one-piece dispensing apparatus 200 .
- a spike guard 146 may be provided to protect users from the sharp spike that may serve as the second activating member.
- Another optional feature of the dispensing apparatus 102 or 200 is an air inlet filter, not shown in the drawings. Such a filter may be useful to prevent particulates from blocking the air vent of the dispensing apparatus 102 and to maintain aseptic conditions.
- the filter may be separate from or combined with a hydrophobic membrane.
- FIG. 10 illustrates an alternate cassette 300 having an outer surface with a recessed portion 302 .
- a valve 304 is situated at the recessed portion of the cassette, reducing the likelihood that the valve or the valve connection to a container will be bumped or damaged during handling.
- the valve at the transfer port can be located in many different locations on the housing of the cassette in addition to the positions illustrated in FIG. 1 and in FIG. 10.
- the valve may be located near the pressure plate 106 .
- the valve could be recessed into the cassette housing in many ways. Any valve location that permits fluid communication with the inner reservoir 108 is within the scope of the present invention.
- the cassette 100 is provided to the patient filled with a liquid such as a diluent liquid.
- a liquid such as a diluent liquid.
- the flexible conduit 120 is closed using a clamp 160 , for example, that pinches the flexible conduit 120 .
- the patient may then remove the cap 144 from the valve 124 on the cassette.
- the dispensing apparatus 102 or 200 is coupled to the second portion 128 of the valve 124 .
- the spike guard 146 is removed from the spike 134 .
- the second activating member 132 or 204 is then used to pierce the septum 158 , allowing a passage to be open to the cassette.
- the system is positioned with the cassette 100 on top, so that at least some of the liquid within the cassette 100 will flow into the medicant container 104 , as shown in FIG. 3. by arrow 148 .
- the liquid is thereby mixed with the powdered drug within the medicant container.
- the positioning of the system is then reversed so the medicant container 104 is on top, causing the mixed liquid drug within the medicant container 104 to flow through the dispensing apparatus 102 or 200 into the cassette 100 as indicated by arrow 150 in FIG. 4.
- the system may be tipped back and forth, as desired, to ensure complete mixing. Using this method, a user may easily and quickly reconstitute a powdered drug with a liquid at a location remote from a caregiver's office.
- the present invention has been described thus far by way of example where the powdered drug is initially stored in the medicant container 104 , and a liquid initially is stored in the cassette 100 .
- a cassette 180 initially containing the powdered drug is also possible.
- the cassette 180 is constructed in a similar manner as the cassette 100 , noted above.
- a medicant container 182 would contain a liquid, as shown in FIG. 9.
- the powdered drug would be mixed by connecting a dispensing apparatus 186 with the valve 124 and the medicant container 182 in a similar manner as noted above.
- the system would first be positioned with the container 182 on top, allowing the liquid to flow into the inner reservoir 183 as indicated by the arrow 184 .
- a mechanism for allowing the fluid to flow into the cassette is desirable with this type of arrangement.
- an air vent may be provided on the connection between the medicant container and the cassette.
- a syringe could also be attached to the delivery tube to draw fluid from the medicant container into the cassette.
- a flexible medicant container could be used that could be squeezed to force fluid into the cassette.
- the dispensing apparatus 186 may then be disconnected from the cassette 180 , and the cassette may be shaken to mix the powdered drug with the liquid.
- the pumping mechanism 172 may be utilized in the method of the present invention to ensure that the reconstituted drug is thoroughly mixed, as illustrated in FIG. 12.
- the delivery conduit 120 may be connected using a luer fitting 210 to the valve 124 . If the delivery conduit 120 is then acted upon by the pumping pads 172 , the reconstituted drug 212 will be circulated within a closed system defined by the delivery conduit 120 and the inner reservoir 108 .
- the drug pump 164 may be programmed to perform this mixing function for a predetermined amount of time. The amount of time for which mixing is performed in this manner may depend on the type of drug that is being reconstituted and its ability to dissolve within the diluent.
- the cassette 100 is filled with a liquid drug for administration to a patient and the transfer port 118 is utilized during the filling process to prevent air from being trapped in the inner reservoir 108 or delivery conduit 120 .
- One source of trapped air is residual air that is in the inner reservoir 108 before it is filled.
- this trapped air may be removed by attaching a syringe or other vacuum source to a second opening in the cassette, such as the transfer port.
- a small amount, or a first amount, of the drug is introduced into the cassette 100 .
- the first amount of drug may be introduced to the inner reservoir of the cassette through the delivery conduit. Enough drug is introduced so that the delivery conduit is full, pushing all air that previously was in the delivery conduit into the inner reservoir.
- the introduction of the first amount of drug into the cassette can take place in many different ways.
- a pharmacist may have a bulk dispensing pump 220 that is designed to pump the drug from, for example, a bulk supply reservoir container 222 , into the delivery conduit 120 .
- a conduit 223 may be coupled to an opening on the bulk reservoir 222 , pass through the dispensing pump 220 , and then connect to the connector 109 on the delivery conduit 120 .
- the bulk dispensing pump 220 acts with a pumping action that is the reverse of the pumping action used when delivering drug from the inner reservoir to a patient.
- many devices other than a bulk dispensing pump may be used to introduce the first amount of drug to the cassette, including a syringe, a pressurized supply or another pumping mechanism.
- the delivery conduit 120 is clamped between the cassette and the drug supply using clamp 224 .
- the delivery conduit 120 between the drug supply and the clamp 224 is filled with the drug and contains minimal, if any, trapped air.
- a syringe 226 or vacuum source attached to the transfer port may be activated.
- the syringe 226 or vacuum source may alternately be attached before the introduction of the drug into the delivery conduit 120 , if the tube 228 leading to the syringe 226 is clamped during introduction of the first amount, using a clamp 230 .
- the inner reservoir 108 and delivery conduit 120 up to the clamp 224 will be mostly devoid of gas and the first amount of drug.
- the valve at the transfer port 112 is then closed, or the clamp 230 is placed on the tube that leads away from the transfer port 112 .
- a second amount of the drug is introduced into the cassette through the first access port 110 .
- the second amount of the drug is introduced into the inner reservoir 108 of the cassette 100 via the delivery conduit 120 .
- the second amount of drug enters the evacuated inner reservoir 108 and air is therefore not trapped inside the inner reservoir 108 .
- the second amount of drug fills the inner reservoir 108 with the amount of drug necessary for providing the cassette to the patient.
- the luer-activated valve may be opened by the pressure differential caused when the vacuum source is attached to the delivery conduit of the cassette.
- the luer-activated valve, or other valve used at the transfer port will be configured to require more force to open the valve than is applied by the vacuum source.
- a tamper-resistant cap such as cap 144
- the cap may be placed on the transfer port by a pharmacist or care provider after filling the cassette in order to offer additional security for the cassette. Tamper-resistant caps and other security features are especially important in the area of pain control. Many locking mechanisms to secure the cap 144 are well-known in the art, and may be used with the present invention.
Abstract
Description
- The present invention is directed to a cassette for use with a drug pump for administering drugs and a method for administering drugs, and more particularly to a cassette and method that allows improved filling of a cassette with a drug.
- Various ambulatory medical devices are known for treating and/or monitoring patients at a remote site away from the caregiver's or clinician's office. One example of an ambulatory medical device is a drug delivery device, such as a drug pump, for providing periodic or continuous drug delivery to the patient when the patient is away from the caregiver's office. Ambulatory drug pumps are shown for example in U.S. Pat. Nos. 4,559,038, 5,531,697 and 5,695,473, the disclosures of which are incorporated by reference.
- Certain drugs rarely achieve their maximum therapeutic action through conventional injection techniques. Many drugs reach their full potential only through precise delivery over an extended period of time. With controlled drug infusion through a drug pump, the drug can be given at a precise rate that will keep the drug concentration within the therapeutic margin and out of the toxic range. Ambulatory drug pumps can provide appropriate drug delivery to the patient at a controllable rate which does not require frequent medical attention and which allows the patient to leave the hospital or caregiver's office.
- Ambulatory drug pumps typically provide the patient with a drug or agent in liquid form, administering the liquid to the patient through a flexible conduit. Some drugs are sold in a powdered form. Examples of drugs on the market today that are sold in powder form include ampicillin, vancomycin hydrochloride, penicillin, nafcillin, and Desferal™ deferoxamine mesylate. Before powdered drugs are administered, they must be mixed with a liquid agent. When powdered drugs are dispensed at pharmacies, the pharmacist typically adds a liquid agent, such as a diluent, to the powdered drug at the pharmacy and then gives the drug to the patient in a liquid form, for example, in a drug pump cassette. The patient could then use the liquid drug with an ambulatory drug pump. Examples of liquid agents that may be mixed with powdered drugs are sterile water, dextrose and saline. These mixing steps require significant pharmacist time and may cause a long wait for a patient who is filling the prescription. Current ambulatory drug pump cassettes do not conveniently allow the patient to perform the dilution or reconstitution of a powdered drug, so the patient must visit the pharmacist.
- Certain types of drugs, such as ampicillin, have limited stability in liquid form. These drugs must be mixed with a liquid agent only a short period of time before they are administered to the patient. The short-lived stability of these drugs necessitates frequent trips by the patient to pick up the diluted drug or frequent deliveries of the diluted drug to the patient's location. In the alternative, some patients are taught to mix drugs with a liquid agent at home. If known drug cassette configurations are used, this process may be awkward and cumbersome for the patient.
- Another problem with filling cassettes for ambulatory drug pumps is the elimination of air from the reservoir within the cassette. Typically, cassettes are filled by injecting fluid through a delivery conduit that is connected to the cassette reservoir. The delivery conduit is a tube that connects the cassette to the patient for drug delivery. Pharmacists will typically use a syringe or a pump to move the drug to be administered into the cassette reservoir. After the cassettes are filled, however, trapped air may be present in the cassette reservoir. Typically, the pharmacist will manually remove the trapped air from the cassette reservoir.
- In one technique for manually removing trapped air, the cassette is tapped until all the air bubbles have collected, and can be drawn out with a syringe. This process is repeated until all of the air bubbles have been removed. The method is time-consuming and labor-intensive for the pharmacist.
- There is a need for drug delivery systems and methods which address the above-mentioned concerns, concerns about drugs that require dilution and/or reconstitution before administration, and concerns about trapped air in the cassette reservoir.
- The present invention concerns a drug pump cassette, including a housing that defines a transfer opening and a delivery opening. The cassette also includes an inner reservoir located within the housing. An access device, or valve, is also provided on the cassette. The valve has a first portion coupled to the inner reservoir at a transfer port and has a second portion coupled to the housing at the transfer opening. The cassette also includes a delivery conduit coupled to the inner reservoir at a delivery port, and emerging from the delivery opening of the cassette.
- Preferably, the housing further includes a pressure plate supporting a portion of the delivery conduit. The pressure plate may be mounted to a control module of a pump.
- The drug cassette may also include a dispensing apparatus. The dispensing apparatus defines a passage and has a first activating device and a second activating device. The first activating device of the dispensing apparatus opens the valve of the cassette. The second activating device establishes fluid communication with a medicant container. The second activating device may include a spike used to pierce a septum of the medicant container, and an air vent to the atmosphere. The air vent may be provided with a filter.
- In one method in accordance with the present invention, a liquid from a cassette is mixed with a powdered drug in a medicant container and the mixture is transferred back to the cassette. In an alternative method, a liquid from a container is mixed with a powdered drug in a cassette reservoir.
- In a method for filling a cassette in accordance with the present invention, the inner reservoir of the cassette is evacuated through a second access port before filling the inner reservoir with the drug through the first access port, thereby providing a filled cassette with minimized trapped air.
- FIG. 1 is a perspective view of one embodiment of a cassette for use with a drug, a dispensing apparatus, and a medicant container.
- FIG. 2 is a side view of the cassette of FIG. 1 where the components are connected.
- FIG. 3 is a side view of the connected cassette of FIG. 2, positioned so that liquid within the cassette flows into the medicant container.
- FIG. 4 is a side view of the connected cassette of FIG. 2 positioned so that the drug in the medicant container flows back into the inner fluid reservoir of the cassette.
- FIG. 5A is a side view of a luer-activated valve that may be used with the cassette of FIG. 1.
- FIG. 5B is a cross-sectional side view of the luer-activated valve of FIG. 5A.
- FIG. 6A is a front view of a first embodiment of a dispensing apparatus for use with the present invention.
- FIG. 6B is a side view of the dispensing apparatus of FIG. 6A.
- FIG. 6C is a cross-sectional side view of the dispensing apparatus of FIG. 6A.
- FIG. 7 is a cross-sectional side view of a first portion of a second embodiment of a dispensing apparatus of the present invention.
- FIG. 8A is a front view of a second portion of the second embodiment of the dispensing apparatus of the present invention.
- FIG. 8B is a side view of the second portion of the dispensing apparatus of FIG. 8A.
- FIG. 8C is a cross-sectional side view of the second portion of the dispensing apparatus of FIG. 8A.
- FIG. 9 is a side view of an alternative embodiment of the cassette of the present invention where the components are connected in which an inner reservoir contains a powdered drug and a medicant container contains diluent liquid.
- FIG. 10 is a side view of an alternative embodiment of a cassette for use when mixing a drug or when using a method of the present invention to fill the cassette while minimizing trapped air.
- FIG. 11 is a perspective view of a drug pump control module.
- FIG. 12 is a side view of the cassette of the present invention during a mixing step.
- FIG. 13 is a plan view of a cassette filling system of the present invention for minimizing trapped air in the cassette.
- The present invention is applicable to a variety of systems and arrangements which are used to mix drugs before administration or to fill a cassette while minimizing trapped air before administration. The invention is advantageous in environments where a drug requires dilution or reconstitution immediately before administration. A cassette is described herein that allows a person, such as a patient, to easily mix a powdered drug with a liquid for administration with an ambulatory drug pump. The cassette of the present invention further enables the filling of the cassette so that trapped air is minimized.
- The cassette of the present invention includes an access mechanism that allows a user to empty at least a portion of liquid contents of the cassette into a medicant container to mix and/or dilute the drug in the container. The access mechanism then allows the user to transfer the mixed together contents of the container to the cassette for use with the drug pump. Alternatively, the access mechanism allows a user to add liquid to a powdered drug in the cassette. The access mechanism further permits evacuation of an inner reservoir of the cassette so that trapped air in the inner reservoir and a delivery conduit can be reduced before filling with a liquid drug.
- Referring now to FIGS.1-12, a
system 20 including acassette 100, adispensing apparatus 102, and amedicant container 104 is shown according to one embodiment of the present invention. Thecassette 100 is designed for use with a drug pump (or control module) 164 as shown in FIG. 11. Apressure plate 106 of thecassette 100 mounts to thecontrol module 164 with twohooks 166 and ananchor 168, illustrated in FIG. 1. The twohooks 166 engage twopins 188. Alatch 189 within the control module engages theanchor 168. Thecassette 100 further includes aninner reservoir 108, such as a flexible polymeric bag. During administration of a liquid drug to a patient, theinner fluid reservoir 108 will contain the liquid drug. The inner fluid reservoir includes two openings: adelivery port 110 and atransfer port 112, illustrated in FIG. 2. - The two
ports inner reservoir 108 each communicate with openings in ahousing 114 of thecassette 100. Thehousing 114 defines adelivery opening 116 and atransfer opening 118. At thedelivery port 110 of theinner reservoir 108, theinner reservoir 108 is connected to adelivery conduit 120, such as a compressible polymeric tube that emerges from thedelivery opening 116 of thehousing 114. Thedelivery conduit 120 is supported by thepressure plate 106 of thecassette 100. The portion of the delivery conduit that is supported on thepressure plate 106 is thepump portion 122 of thedelivery conduit 120. In the illustrated embodiment, thepump portion 122 may be larger in size than the remainder of thedelivery conduit 120. When thecassette 100 is mounted to thecontrol module 164, a pumping mechanism 172 (FIG. 11) of thecontrol module 164 will act on thepump portion 122 to draw the liquid drug out of theinner reservoir 108 and move it along thedelivery conduit 120. Thedelivery conduit 120 is connected to a patient for drug delivery. A luer fitting 109 or another type of connector and acap 111 may be provided at the end of thedelivery conduit 120. - The
cassette 100 also includes an access mechanism for allowing selective access to the interior of theinner reservoir 108. One preferred access mechanism includes avalve 124 capable of establishing fluid communication with theinner reservoir 108 in order to allow mixing with the contents of another container, such as themedicant container 104. A dispensingapparatus 102 links thevalve 124 of thecassette 100 with themedicant container 104. Thevalve 124 of the illustrated preferred embodiment includes afirst portion 126 that is operatively coupled to theinner fluid reservoir 108 atport 112. Thevalve 124 further includes asecond portion 128 that is attached to thehousing 114 of thecassette 100 attransfer opening 118. Thevalve 124 is capable of establishing fluid communication with the dispensingapparatus 102 when activated by the dispensingapparatus 102. Thevalve 124 may be, for example, a luer-activated valve having a stoppingmember 152 that can be depressed by a luer fitting to open apassage 154, as illustrated in FIGS. 5A and 5B. A biasingmember 162 holds the stoppingmember 152 into engagement with the interior neck portion of thevalve 124. - For use with such a luer-activated valve, the first activating
member 130 of thedispensing apparatus 102 may be a luer fitting that depresses the stoppingmember 152. Many luer-activated valves are commercially available that may vary from the valve shown in FIGS. 5A and 5B, but could be used with the present invention. - Dilution of a drug, where the concentration of an active material is reduced, may easily be practiced using the present invention. The present invention is useful where two drug components must be mixed prior to administration to a patient using a cassette. Possible drug mixtures that could be carried out with the present invention include combining two liquids, or a solid and a liquid.
- In use, the
cassette 100 is attached to the dispensingmember 102, and fluid communication is established between the dispensingmember 102 and themedicant container 104. In a preferred embodiment, thecassette 100 will initially contain aliquid diluent 107 to be mixed with a powdered drug. Examples of diluents include sterile water, saline, and dextrose. Thecassette 100 may also initially contain another type of liquid agent for mixing with a powdered drug. - In the embodiment of FIG. 1, the
medicant container 104 initially contains apowdered drug 105 to be administered to a patient. The dispensingapparatus 102 has a second activatingmember 132 for establishing fluid communication with themedicant container 104. Themedicant container 104 may be a vial with a sealed,pierceable septum 158. In this case, the second activating member is aspike 134 that pierces theseptum 158 and provides a passageway to thevalve 124. As discussed above, the dispensing apparatus also has a first activating member that is designed to open thevalve 124, such as a luer fitting ifvalve 124 is a luer-activated valve. - In the embodiment illustrated in FIG. 1, the dispensing
apparatus 102 includes two parts, a vented dispensingpin 138 and a male-to-male luer adapter 140. However, a onepiece dispersing apparatus 200 could be used in place of the twopiece dispensing apparatus 102. The one piece dispensing apparatus is illustrated in FIGS. 6A-6C and is discussed further below. - The two
piece dispensing apparatus 102 is illustrated in FIG. 1. Theventing dispensing pin 138 includes the second activating member, or spike, 134, as shown in FIGS. 8A-8C. The male-to-male luer adapter 140 includes the first activating member, aluer 136 for activating thevalve 124 as shown in FIG. 7. The vented dispensingpin 138 includes a luer lock that attaches to the opposite end of the male-to-male luer adapter 140, providing a passage for fluid communication. - The
dispensing apparatus 102 may be provided with anair vent 142 to more easily enable the flow of liquid between the cassette and themedicant container 104 by permitting displaced air or other gas to escape and allowing air to enter the connected cassette assembly, specifically themedicant container 104. Theair vent 142 is constructed according to known methods for permitting the flow of gas, but preventing the flow of liquid. For example, theair vent 142 may include a hydrophobic membrane that is penetrable by gases but not by fluids. Vented dispensingpin 138 and male-to-male luer adapter 140 are commercially available as separate components. One example of adispensing pin 138 that could be used as a portion of thedispensing apparatus 102 is the DP-1000 Mini-Spike® dispensing pin assembly, manufactured by Burron OEM, a division of B. Braun Medical, Inc. - Referring now to FIG. 6A and FIG. 8A, the
preferred air vents shield structure vent vent - One example of a male-to-
male luer adapter 140 that could be used as part of thedispensing apparatus 102 is the male/male luer lock connector, Model No. B1000200, manufactured by Burron OEM, a division of B. Braun Medical, Inc. The male-to-male luer adapter may be constructed of polycarbonate ABS, polypropylene or other similar material and is shown in FIG. 7 in detail. Theadapter 140 defines apassage 190. The luer fitting 136 of theadapter 140 depresses the stoppingmember 152 of thevalve 124 when theadapter 140 is connected to thevalve 124. A second luer fitting 137 may also be included on theadapter 140. Acap 144 may be used to protect thevalve 124 before and after the mixing process and maintain aseptic conditions. - In an alternative embodiment, a
dispensing apparatus 200 could be made of only one piece as shown in FIG. 6A-6C, having both a first activatingmember 202 and a second activatingmember 204 on the same body connected in a permanent manner. In this embodiment there are fewer components for a user to connect. - The one-
piece dispensing apparatus 200 may include a luer fitting as the first activatingmember 202. The first activatingmember 202 is designed to establish fluid communication with thevalve 124. The first activatingmember 202, or luer, may also include threads along thewall 205, for receiving and securing the luer-activated valve or other type of valve. The threads would be similar to those illustrated in FIG. 7 near the activatingmembers member 204 may be a spike to pierce the septum of the medicant vial. The one-piece dispensing apparatus 200 also defines apassage 206 through its length. Anair vent 208 may also be provided on the one-piece dispensing apparatus 200. - A
spike guard 146 may be provided to protect users from the sharp spike that may serve as the second activating member. Another optional feature of thedispensing apparatus dispensing apparatus 102 and to maintain aseptic conditions. The filter may be separate from or combined with a hydrophobic membrane. - FIG. 10 illustrates an
alternate cassette 300 having an outer surface with a recessedportion 302. Avalve 304 is situated at the recessed portion of the cassette, reducing the likelihood that the valve or the valve connection to a container will be bumped or damaged during handling. The valve at the transfer port can be located in many different locations on the housing of the cassette in addition to the positions illustrated in FIG. 1 and in FIG. 10. For example, the valve may be located near thepressure plate 106. Alternatively, the valve could be recessed into the cassette housing in many ways. Any valve location that permits fluid communication with theinner reservoir 108 is within the scope of the present invention. - In one method of the present invention, the
cassette 100 is provided to the patient filled with a liquid such as a diluent liquid. Theflexible conduit 120 is closed using aclamp 160, for example, that pinches theflexible conduit 120. The patient may then remove thecap 144 from thevalve 124 on the cassette. The dispensingapparatus second portion 128 of thevalve 124. Thespike guard 146 is removed from thespike 134. The second activatingmember septum 158, allowing a passage to be open to the cassette. - After the
cassette 100, the dispensingapparatus medicant container 104 are connected in fluid communication, the system is positioned with thecassette 100 on top, so that at least some of the liquid within thecassette 100 will flow into themedicant container 104, as shown in FIG. 3. byarrow 148. The liquid is thereby mixed with the powdered drug within the medicant container. The positioning of the system is then reversed so themedicant container 104 is on top, causing the mixed liquid drug within themedicant container 104 to flow through the dispensingapparatus cassette 100 as indicated byarrow 150 in FIG. 4. The system may be tipped back and forth, as desired, to ensure complete mixing. Using this method, a user may easily and quickly reconstitute a powdered drug with a liquid at a location remote from a caregiver's office. - The present invention has been described thus far by way of example where the powdered drug is initially stored in the
medicant container 104, and a liquid initially is stored in thecassette 100. However, as shown in FIG. 9, it is also possible to provide acassette 180 initially containing the powdered drug. Thecassette 180 is constructed in a similar manner as thecassette 100, noted above. In this case, amedicant container 182 would contain a liquid, as shown in FIG. 9. The powdered drug would be mixed by connecting adispensing apparatus 186 with thevalve 124 and themedicant container 182 in a similar manner as noted above. The system would first be positioned with thecontainer 182 on top, allowing the liquid to flow into the inner reservoir 183 as indicated by thearrow 184. A mechanism for allowing the fluid to flow into the cassette is desirable with this type of arrangement. For example, an air vent may be provided on the connection between the medicant container and the cassette. A syringe could also be attached to the delivery tube to draw fluid from the medicant container into the cassette. A flexible medicant container could be used that could be squeezed to force fluid into the cassette. The dispensingapparatus 186 may then be disconnected from thecassette 180, and the cassette may be shaken to mix the powdered drug with the liquid. - The
pumping mechanism 172 may be utilized in the method of the present invention to ensure that the reconstituted drug is thoroughly mixed, as illustrated in FIG. 12. Thedelivery conduit 120 may be connected using a luer fitting 210 to thevalve 124. If thedelivery conduit 120 is then acted upon by thepumping pads 172, the reconstituteddrug 212 will be circulated within a closed system defined by thedelivery conduit 120 and theinner reservoir 108. Thedrug pump 164 may be programmed to perform this mixing function for a predetermined amount of time. The amount of time for which mixing is performed in this manner may depend on the type of drug that is being reconstituted and its ability to dissolve within the diluent. - In another method of the present invention, the
cassette 100 is filled with a liquid drug for administration to a patient and thetransfer port 118 is utilized during the filling process to prevent air from being trapped in theinner reservoir 108 ordelivery conduit 120. One source of trapped air is residual air that is in theinner reservoir 108 before it is filled. In the method of the present invention, this trapped air may be removed by attaching a syringe or other vacuum source to a second opening in the cassette, such as the transfer port. According to the invention, a small amount, or a first amount, of the drug is introduced into thecassette 100. The first amount of drug may be introduced to the inner reservoir of the cassette through the delivery conduit. Enough drug is introduced so that the delivery conduit is full, pushing all air that previously was in the delivery conduit into the inner reservoir. - The introduction of the first amount of drug into the cassette can take place in many different ways. For example, as illustrated in FIG. 13 a pharmacist may have a
bulk dispensing pump 220 that is designed to pump the drug from, for example, a bulksupply reservoir container 222, into thedelivery conduit 120. Aconduit 223 may be coupled to an opening on thebulk reservoir 222, pass through the dispensingpump 220, and then connect to theconnector 109 on thedelivery conduit 120. Thebulk dispensing pump 220 acts with a pumping action that is the reverse of the pumping action used when delivering drug from the inner reservoir to a patient. Further, many devices other than a bulk dispensing pump may be used to introduce the first amount of drug to the cassette, including a syringe, a pressurized supply or another pumping mechanism. - Once the
delivery conduit 120 is filled with the first amount of drug, thedelivery conduit 120 is clamped between the cassette and the drugsupply using clamp 224. At this point, thedelivery conduit 120 between the drug supply and theclamp 224 is filled with the drug and contains minimal, if any, trapped air. Then, asyringe 226 or vacuum source attached to the transfer port may be activated. Thesyringe 226 or vacuum source may alternately be attached before the introduction of the drug into thedelivery conduit 120, if thetube 228 leading to thesyringe 226 is clamped during introduction of the first amount, using aclamp 230. After the syringe or other vacuum source has evacuated theinner reservoir 108 through thetransfer port 112, or second access port, theinner reservoir 108 anddelivery conduit 120 up to theclamp 224 will be mostly devoid of gas and the first amount of drug. The valve at thetransfer port 112 is then closed, or theclamp 230 is placed on the tube that leads away from thetransfer port 112. - Next, a second amount of the drug is introduced into the cassette through the
first access port 110. Preferably, the second amount of the drug is introduced into theinner reservoir 108 of thecassette 100 via thedelivery conduit 120. The second amount of drug enters the evacuatedinner reservoir 108 and air is therefore not trapped inside theinner reservoir 108. Preferably, the second amount of drug fills theinner reservoir 108 with the amount of drug necessary for providing the cassette to the patient. - The system and method for filling and minimizing entrapped air has thus far been described for use with a
cassette 100 where adelivery conduit 120 is attached to the drug supply and thevalve 124 at thetransfer port 118 is attached to a syringe or vacuum source. However, it is also possible to utilize the method of the present invention where the vacuum source is attached to thedelivery conduit 120 and a drug supply is attached to thevalve 124 at thetransfer port 118. The steps discussed above would similarly be carried out in this scenario. One consideration when utilizing this embodiment is that most luer-activated valves, and other types of valves, open when a spring-loaded plunger is depressed. It is possible, therefore, that the luer-activated valve may be opened by the pressure differential caused when the vacuum source is attached to the delivery conduit of the cassette. In this scenario, the luer-activated valve, or other valve used at the transfer port, will be configured to require more force to open the valve than is applied by the vacuum source. - A tamper-resistant cap, such as
cap 144, may be supplied for the valve. The cap may be placed on the transfer port by a pharmacist or care provider after filling the cassette in order to offer additional security for the cassette. Tamper-resistant caps and other security features are especially important in the area of pain control. Many locking mechanisms to secure thecap 144 are well-known in the art, and may be used with the present invention. - The various embodiments described above are provided by way of illustration only and should not be construed to limit the invention. Those skilled in the art will readily recognize various modifications and changes which may be made to the present invention without strictly following the exemplary embodiments and applications illustrated and described herein, and without departing from the true spirit and scope of the present invention which is set forth in the following claims.
Claims (32)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/809,479 US6374876B2 (en) | 1998-11-09 | 2001-03-15 | Fillable cassette apparatus and method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/189,379 US6202708B1 (en) | 1998-11-09 | 1998-11-09 | Fillable cassette apparatus and method |
US09/809,479 US6374876B2 (en) | 1998-11-09 | 2001-03-15 | Fillable cassette apparatus and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/189,379 Division US6202708B1 (en) | 1998-11-09 | 1998-11-09 | Fillable cassette apparatus and method |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010010238A1 true US20010010238A1 (en) | 2001-08-02 |
US6374876B2 US6374876B2 (en) | 2002-04-23 |
Family
ID=22697084
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/189,379 Expired - Lifetime US6202708B1 (en) | 1998-11-09 | 1998-11-09 | Fillable cassette apparatus and method |
US09/809,479 Expired - Lifetime US6374876B2 (en) | 1998-11-09 | 2001-03-15 | Fillable cassette apparatus and method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/189,379 Expired - Lifetime US6202708B1 (en) | 1998-11-09 | 1998-11-09 | Fillable cassette apparatus and method |
Country Status (3)
Country | Link |
---|---|
US (2) | US6202708B1 (en) |
AU (1) | AU1466000A (en) |
WO (1) | WO2000027451A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090157005A1 (en) * | 2003-04-23 | 2009-06-18 | Gonnelli Robert R | Hydraulically actuated pump for long duration medicament administration |
US7914499B2 (en) | 2006-03-30 | 2011-03-29 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US20120029428A1 (en) * | 2009-04-08 | 2012-02-02 | Neer Charles S | Vacuum Asisst Syringe Filling |
US8974415B2 (en) | 2012-04-10 | 2015-03-10 | Smiths Medical Asd, Inc. | Flow stop insert apparatus and methods |
US9089636B2 (en) | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US9662437B2 (en) | 2014-04-28 | 2017-05-30 | Smiths Medical Asd, Inc. | Infusion pump pressure plate |
CN110841145A (en) * | 2019-12-20 | 2020-02-28 | 厦门华厦学院 | Automated drug delivery system |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699230B2 (en) * | 2000-05-10 | 2004-03-02 | Minnesota Medical Physics, Llc | Apparatus and method for out-of-hospital thrombolytic therapy |
US8034026B2 (en) | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
EP2140891B1 (en) | 2001-05-18 | 2013-03-27 | DEKA Products Limited Partnership | Conduit for coupling to a fluid delivery device |
AU2002322763B2 (en) * | 2001-07-31 | 2007-08-09 | Scott Laboratories, Inc. | Apparatuses and methods for providing IV infusion administration |
WO2003035119A1 (en) * | 2001-10-26 | 2003-05-01 | Liberto Frank G | A sanitizing pouch and method of use therefor |
CA2486005C (en) * | 2002-05-16 | 2008-08-26 | Scott Laboratories, Inc. | Drug container entry mechanisms and method |
EP2275157A3 (en) | 2002-05-16 | 2012-02-15 | Scott Laboratories, Inc. | Kits of medical supplies for sedation and analgesia |
WO2004087320A2 (en) * | 2003-03-28 | 2004-10-14 | Hyclone Laboratories, Inc. | Fluid dispensing bins and related methods |
JP4518918B2 (en) * | 2003-11-20 | 2010-08-04 | ミリポア・コーポレイション | Fluid dispensing device |
US20060184103A1 (en) * | 2005-02-17 | 2006-08-17 | West Pharmaceutical Services, Inc. | Syringe safety device |
US7981090B2 (en) | 2006-10-18 | 2011-07-19 | Baxter International Inc. | Luer activated device |
US8221363B2 (en) | 2006-10-18 | 2012-07-17 | Baxter Healthcare S.A. | Luer activated device with valve element under tension |
US7753338B2 (en) | 2006-10-23 | 2010-07-13 | Baxter International Inc. | Luer activated device with minimal fluid displacement |
US8123716B1 (en) * | 2007-06-26 | 2012-02-28 | Pacesetter, Inc. | Pericardial delivery of treatment |
US7740212B2 (en) * | 2008-04-17 | 2010-06-22 | ConeCraft, Inc, | Apparatus to retain and position tubing of media bags |
US8262616B2 (en) | 2008-10-10 | 2012-09-11 | Deka Products Limited Partnership | Infusion pump assembly |
US8223028B2 (en) | 2008-10-10 | 2012-07-17 | Deka Products Limited Partnership | Occlusion detection system and method |
US8267892B2 (en) | 2008-10-10 | 2012-09-18 | Deka Products Limited Partnership | Multi-language / multi-processor infusion pump assembly |
US8016789B2 (en) | 2008-10-10 | 2011-09-13 | Deka Products Limited Partnership | Pump assembly with a removable cover assembly |
US8066672B2 (en) | 2008-10-10 | 2011-11-29 | Deka Products Limited Partnership | Infusion pump assembly with a backup power supply |
US9180245B2 (en) | 2008-10-10 | 2015-11-10 | Deka Products Limited Partnership | System and method for administering an infusible fluid |
US8708376B2 (en) | 2008-10-10 | 2014-04-29 | Deka Products Limited Partnership | Medium connector |
DK2258333T3 (en) * | 2009-06-02 | 2012-12-10 | Hoffmann La Roche | Apparatus for filling a flexible container |
CN102724946B (en) | 2009-07-29 | 2015-06-10 | Icu医学有限公司 | Fluid transfer devices and methods of use |
EP3284494A1 (en) | 2009-07-30 | 2018-02-21 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
US7967773B2 (en) * | 2009-10-13 | 2011-06-28 | Smiths Medical Asd, Inc. | Two piece medication cassette closure apparatus and method |
EP2896394A1 (en) * | 2010-01-29 | 2015-07-22 | KCI Licensing Inc. | Systems and methods for positioning fluid supply system |
US9376655B2 (en) | 2011-09-29 | 2016-06-28 | Life Technologies Corporation | Filter systems for separating microcarriers from cell culture solutions |
US20130146174A1 (en) * | 2011-12-12 | 2013-06-13 | Parker Laboratories, Inc. | Adaptor for connecting a fluid package to a dispenser bottle |
AU2012324021A1 (en) | 2011-12-22 | 2013-07-11 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US9468715B2 (en) | 2012-09-17 | 2016-10-18 | Micrel Medical Devices S.A. | Infusion rotary peristaltic pump |
WO2014062403A1 (en) * | 2012-10-15 | 2014-04-24 | Smiths Medical Asd, Inc. | Infusion system disposable alignment system |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US9393177B2 (en) * | 2013-08-20 | 2016-07-19 | Anutra Medical, Inc. | Cassette assembly for syringe fill system |
AU2014353184B2 (en) | 2013-11-25 | 2017-08-17 | Icu Medical, Inc. | Methods and system for filling IV bags with therapeutic fluid |
USD763433S1 (en) | 2014-06-06 | 2016-08-09 | Anutra Medical, Inc. | Delivery system cassette |
USD774182S1 (en) | 2014-06-06 | 2016-12-13 | Anutra Medical, Inc. | Anesthetic delivery device |
US9987416B2 (en) * | 2015-01-09 | 2018-06-05 | BioQuiddity Inc. | Sterile assembled liquid medicament dosage control and delivery device |
CN112245287A (en) * | 2015-03-26 | 2021-01-22 | 因内博注射剂公司 | Pressurized gas driven drug transfer and resuspension apparatus and method |
US10085915B2 (en) | 2015-04-07 | 2018-10-02 | Ent Solutions Group, Llc | Safety fluid dispenser |
EP3383343A4 (en) | 2015-12-04 | 2019-07-10 | ICU Medical, Inc. | Systems methods and components for transferring medical fluids |
USD851745S1 (en) | 2016-07-19 | 2019-06-18 | Icu Medical, Inc. | Medical fluid transfer system |
EP3487468A4 (en) | 2016-07-25 | 2020-03-25 | ICU Medical, Inc. | Systems, methods, and components for trapping air bubbles in medical fluid transfer modules and systems |
US10759584B2 (en) | 2018-03-02 | 2020-09-01 | Life Technologies Corporation | System for port and tube holder assembly attachment device and methods of use |
US11338082B2 (en) | 2019-09-04 | 2022-05-24 | BloQ Pharma, Inc. | Variable rate dispenser with aseptic spike connector assembly |
US11590057B2 (en) | 2020-04-03 | 2023-02-28 | Icu Medical, Inc. | Systems, methods, and components for transferring medical fluids |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4398908A (en) | 1980-11-28 | 1983-08-16 | Siposs George G | Insulin delivery system |
US4391598A (en) * | 1981-04-28 | 1983-07-05 | Quest Medical, Inc. | Intravenous drug additive delivery system with electronic control |
US4411662A (en) * | 1982-04-06 | 1983-10-25 | Baxter Travenol Laboratories, Inc. | Sterile coupling |
US4410321A (en) | 1982-04-06 | 1983-10-18 | Baxter Travenol Laboratories, Inc. | Closed drug delivery system |
US4657486A (en) | 1984-01-13 | 1987-04-14 | Stempfle Julius E | Portable infusion device |
CA1254091A (en) | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
US4559038A (en) | 1984-10-19 | 1985-12-17 | Deltec Systems, Inc. | Drug delivery system |
DE3687530T2 (en) | 1985-06-27 | 1993-07-22 | Duphar Int Res | SYRINGE. |
US5176634A (en) | 1990-08-02 | 1993-01-05 | Mcgaw, Inc. | Flexible multiple compartment drug container |
US5116316A (en) * | 1991-02-25 | 1992-05-26 | Baxter International Inc. | Automatic in-line reconstitution system |
CH689443A5 (en) | 1992-09-16 | 1999-04-30 | Debiotech Sa | Portable pump assembly for parenteral administration of medicaments |
US5378231A (en) * | 1992-11-25 | 1995-01-03 | Abbott Laboratories | Automated drug infusion system |
US5353961A (en) | 1993-01-15 | 1994-10-11 | Reseal International Limited Partnership | Dual chamber dispenser |
AU5637094A (en) | 1993-03-16 | 1994-09-22 | Clintec Nutrition Company | Peelable seal and container having same |
US5558639A (en) | 1993-06-10 | 1996-09-24 | Gangemi; Ronald J. | Ambulatory patient infusion apparatus |
US5462526A (en) | 1993-09-15 | 1995-10-31 | Mcgaw, Inc. | Flexible, sterile container and method of making and using same |
US5540561A (en) | 1993-10-28 | 1996-07-30 | Sims Deltec, Inc. | Reservoir enclosure arrangements |
US5531697A (en) | 1994-04-15 | 1996-07-02 | Sims Deltec, Inc. | Systems and methods for cassette identification for drug pumps |
US5478211A (en) | 1994-03-09 | 1995-12-26 | Baxter International Inc. | Ambulatory infusion pump |
US5695473A (en) | 1994-07-27 | 1997-12-09 | Sims Deltec, Inc. | Occlusion detection system for an infusion pump |
US5788671A (en) * | 1996-08-14 | 1998-08-04 | Sims Deltec, Inc. | Reusable cassette housings and methods |
-
1998
- 1998-11-09 US US09/189,379 patent/US6202708B1/en not_active Expired - Lifetime
-
1999
- 1999-11-05 WO PCT/US1999/025923 patent/WO2000027451A1/en active Application Filing
- 1999-11-05 AU AU14660/00A patent/AU1466000A/en not_active Abandoned
-
2001
- 2001-03-15 US US09/809,479 patent/US6374876B2/en not_active Expired - Lifetime
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9072828B2 (en) | 2003-04-23 | 2015-07-07 | Valeritas, Inc. | Hydraulically actuated pump for long duration medicament administration |
US20090198185A1 (en) * | 2003-04-23 | 2009-08-06 | Gonnelli Robert R | Hydraulically actuated pump for long duration medicament administration |
US10525194B2 (en) | 2003-04-23 | 2020-01-07 | Valeritas, Inc. | Hydraulically actuated pump for fluid administration |
US8070726B2 (en) | 2003-04-23 | 2011-12-06 | Valeritas, Inc. | Hydraulically actuated pump for long duration medicament administration |
US20090157005A1 (en) * | 2003-04-23 | 2009-06-18 | Gonnelli Robert R | Hydraulically actuated pump for long duration medicament administration |
US9511187B2 (en) | 2003-04-23 | 2016-12-06 | Valeritas, Inc. | Hydraulically actuated pump for fluid administration |
US9125983B2 (en) | 2003-04-23 | 2015-09-08 | Valeritas, Inc. | Hydraulically actuated pump for fluid administration |
US11642456B2 (en) | 2003-04-23 | 2023-05-09 | Mannkind Corporation | Hydraulically actuated pump for fluid administration |
US9089636B2 (en) | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US10493199B2 (en) | 2006-03-30 | 2019-12-03 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US8821443B2 (en) | 2006-03-30 | 2014-09-02 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US8361053B2 (en) | 2006-03-30 | 2013-01-29 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US7914499B2 (en) | 2006-03-30 | 2011-03-29 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US9687599B2 (en) | 2006-03-30 | 2017-06-27 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US20120029428A1 (en) * | 2009-04-08 | 2012-02-02 | Neer Charles S | Vacuum Asisst Syringe Filling |
US9789251B2 (en) | 2012-04-10 | 2017-10-17 | Smiths Medical Asd, Inc. | Flow stop insert apparatus and methods |
US8974415B2 (en) | 2012-04-10 | 2015-03-10 | Smiths Medical Asd, Inc. | Flow stop insert apparatus and methods |
US9662437B2 (en) | 2014-04-28 | 2017-05-30 | Smiths Medical Asd, Inc. | Infusion pump pressure plate |
CN110841145A (en) * | 2019-12-20 | 2020-02-28 | 厦门华厦学院 | Automated drug delivery system |
Also Published As
Publication number | Publication date |
---|---|
US6374876B2 (en) | 2002-04-23 |
US6202708B1 (en) | 2001-03-20 |
AU1466000A (en) | 2000-05-29 |
WO2000027451A1 (en) | 2000-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6374876B2 (en) | Fillable cassette apparatus and method | |
CA1299527C (en) | Needle-pierceable cartridge for drug delivery | |
EP0526623B1 (en) | Automatic in-line reconstitution system | |
AU676566B2 (en) | Vial adapter | |
JP2736509B2 (en) | In-line drug release device and release method for use with a standard intravenous set | |
US5897526A (en) | Closed system medication administering system | |
JP2736510B2 (en) | In-line drug release device and release method for use with a standard intravenous set | |
US6676632B2 (en) | In-line IV drug delivery pack with controllable dilution | |
US5049129A (en) | Adapter for passive drug delivery system | |
US4874366A (en) | Housing enabling passive mixing of a beneficial agent with a diluent | |
US4936829A (en) | Drug delivery apparatus including beneficial agent chamber with chimney for a directed flow path | |
EP0246715A2 (en) | Apparatus for the safe delivery of a beneficial agent to a patient | |
JP5095727B2 (en) | Vented infusion access device | |
US5074844A (en) | Passive drug delivery system | |
EP0267950A1 (en) | Passive drug delivery system. | |
EP0203162A1 (en) | Housing enabling passive mixing of a beneficial agent with a diluent. | |
EP0435860B1 (en) | Adapter for connecting with a drug vial to introduce a beneficial agent to a patient | |
JPH0534990B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DELTEC, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SIMS DELTEC, INC.;REEL/FRAME:012627/0416 Effective date: 20010718 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: SMITHS MEDICAL MD, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:DELTEC, INC.;REEL/FRAME:014863/0522 Effective date: 20031030 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: SMITHS MEDICAL ASD, INC., MINNESOTA Free format text: MERGER;ASSIGNOR:SMITHS MEDICAL MD, INC.;REEL/FRAME:023486/0042 Effective date: 20060806 Owner name: SMITHS MEDICAL MD, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:DELTEC, INC.;REEL/FRAME:023486/0048 Effective date: 20031030 |
|
FPAY | Fee payment |
Year of fee payment: 12 |